Medicover’s annual report, including sustainability report for 2025, has been published today and is now available on the company’s website medicover.com.

Medicover’s annual report, including sustainability report for 2025, has been published today and is now available on the company’s website medicover.com.

Highlights from 2025:

Both divisions, Healthcare Services and Diagnostic Services, performed strongly and contributed to organic revenue growth of 12.7 per cent, with solid development across all key markets. Total revenue amounted to EUR 2,378.1 million.
The three-year financial targets were achieved by increasing organic revenue to EUR 2.3 billion, with an adjusted organic EBITDA of EUR 369 million, with leverage within the target range.
CityFit and local operations from SYNLAB were acquired and successfully integrated. These two acquisitions represent Medicover’s largest acquisitions ever.
Medicover’s climate targets were validated by the Science Based Targets initiative (SBTi).

The annual report is also attached to this press release. The official version of the Annual Report 2025 is prepared in Swedish in the European Single Electronic Format (ESEF). For further information, please contact:Hanna Bjellquist, Head of Investor Relations+46 703 033 272hanna.bjellquist@medicover.com

About UsMedicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2025, Medicover had revenue of €2,378 million and more than 49,000 employees. For more information, go to www.medicover.com

This information is information that Medicover AB (Publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-30 11:00 CEST.

AttachmentsMedicover Annual Report 2025